In these studies, critical COVID-19 outcomes [63], extended hospitalization and lymphopenia in COVID-19 patients [64], and poor prognosis and disease severity [65] were associated with a significant increase in IL-2 cytokine family profile, including IL-2, IL-4, and IL-15. The gene discussed is IL2; the disease is lymphopenia.